Peripheral blood mononuclear cells show markers of mitochondrial dysfunction in rheumatoid arthritis

Anahita Abbasifard,Ghasem Solgi,Iraj Khodadadi,Amin Doosti‐Irani,Heidar Tayebinia,Alireza Fazaeli
DOI: https://doi.org/10.1002/cbf.4025
2024-06-08
Cell Biochemistry and Function
Abstract:Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease. Metabolic and mitochondrial dysregulation are critical causal factors in the pathogenesis and progression of RA. Mitochondrial dysfunction include abnormal energy metabolism, and excessive production of reactive oxygen species (ROS). This study aimed to investigate the adenosine triphosphate (ATP), mitochondrial membrane potential (ΔΨm), ROS, and mRNA expression level of ROMO1 (as ROS modulator) and OMA1 (as regulator mitochondrial dynamics) of peripheral blood mononuclear cells (PBMC) in RA patients. The study participants were 50 patients with RA and 50 sex‐ and age‐matched healthy volunteers. PBMC of all participant were isolated by Ficoll‐Paque. Alteration in ΔΨm and cellular ROS were measured using flow cytometry, ATP level was also assessed via luminometry, and ROMO1 and OMA1 mRNA expression via qRT‐PCR assay. A significant decrease in ATP (p = .005) and ΔΨm (p
cell biology,biochemistry & molecular biology
What problem does this paper attempt to address?